Alterity Therapeutics (ATHE) Interest Coverage Ratio (2019)

Alterity Therapeutics' (ATHE) quarterly Interest Coverage Ratio came in at 2280.81 in Q4 2019.

Alterity Therapeutics (ATHE) Interest Coverage Ratio (2019) Analysis & Trends

Alterity Therapeutics' Interest Coverage Ratio history runs 1 years deep, the most recent figure standing at 2280.81 for Q4 2019.

On a quarterly basis, Interest Coverage Ratio changed N/A year-over-year to 2280.81 in Q4 2019; TTM through Dec 2019 was 13541.91, a N/A change from a year earlier, with the FY2025 full-year figure at 1962.13, up 26.81% from the prior year.
Interest Coverage Ratio was little changed at 2280.81 in Q4 2019 per ATHE's latest filing.
Across five years, Interest Coverage Ratio topped out at 2280.81 in Q4 2019 and bottomed at 2280.81 in Q4 2019.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	658.42
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-157.58
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	7.60
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	2.71
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	22.72
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	-0.38
10	Alterity Therapeutics	29.68 Bn	29.68 Bn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2019	2,280.81